Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Emerging Growth Conference March 17, 2021

0
141

Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) presented on the Emerging Growth Conference on March 17, 2021.

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Tonix is a clinical-stage biopharmaceutical company focused on discovering, licensing, acquiring, and developing small molecules and biologics to treat and prevent human disease and alleviate suffering.